PANCRELIPASE

PANCRELIPASE was reported 39617 times

PANCRELIPASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATICODUODENECTOMY 373 0.5617
1 PANCREATIC STENT PLACEMENT 52 0.4815
2 PANCREATECTOMY 262 0.4695
3 PANCREATIC OPERATION 96 0.4384
4 PANCREATIC FAILURE 686 0.3878
5 PANCREATIC CARCINOMA RECURRENT 68 0.2822
6 CYSTIC FIBROSIS RELATED DIABETES 36 0.2466
7 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1326 0.2434
8 CYSTIC FIBROSIS LUNG 31 0.2422
9 PANCREATIC ENZYMES DECREASED 30 0.2344
10 PANCREATIC ENZYME ABNORMALITY 23 0.2255
11 PANCREATOLITHIASIS 87 0.2180
12 ENZYME LEVEL DECREASED 27 0.2045
13 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 179 0.2004
14 DISTAL INTESTINAL OBSTRUCTION SYNDROME 58 0.1721
15 PANCREATIC DUCT OBSTRUCTION 28 0.1564
16 CYSTIC FIBROSIS 796 0.1436
17 PANCREATITIS CHRONIC 315 0.1329
18 DEHISCENCE 24 0.1270
19 CHEMOTHERAPY 469 0.1239
20 STEATORRHOEA 328 0.1224
21 PANCREATIC ATROPHY 52 0.1190
22 PANCREATIC INSUFFICIENCY 38 0.1053
23 BILE DUCT STENT INSERTION 38 0.0995
24 LIVER OPERATION 26 0.0844
25 PANCREATIC NEOPLASM 101 0.0816
26 PANCREATIC DISORDER 400 0.0811
27 GASTROINTESTINAL MICROORGANISM OVERGROWTH 28 0.0795
28 PANCREATIC DUCT DILATATION 21 0.0764
29 PANCREATIC CYST 143 0.0748
30 PANCREATIC CARCINOMA METASTATIC 207 0.0727
31 PANCREATIC INJURY 22 0.0721
32 PULMONARY FUNCTION TEST DECREASED 305 0.0696
33 PSEUDOCYST 22 0.0683
34 SPLENECTOMY 79 0.0680
35 BILIARY OBSTRUCTION 87 0.0671
36 PANCREATIC MASS 71 0.0664
37 PANCREATITIS RELAPSING 48 0.0587
38 PANCREAS INFECTION 22 0.0547
39 ADENOCARCINOMA PANCREAS 61 0.0475
40 ENZYME ABNORMALITY 25 0.0463
41 PANCREATIC CARCINOMA 1297 0.0449
42 BILIARY TRACT INFECTION 25 0.0402
43 MALABSORPTION 210 0.0402
44 GASTRECTOMY 40 0.0398
45 ADVERSE FOOD REACTION 37 0.0397
46 AUTOIMMUNE PANCREATITIS 20 0.0395
47 GASTRIC OPERATION 36 0.0392
48 LUNG TRANSPLANT REJECTION 24 0.0364
49 PANCREATIC PSEUDOCYST 27 0.0348
50 ABNORMAL FAECES 283 0.0345
51 SPUTUM INCREASED 71 0.0328
52 GASTROINTESTINAL SURGERY 23 0.0299
53 LUNG TRANSPLANT 103 0.0291
54 MEDICAL DEVICE IMPLANTATION 44 0.0280
55 GASTROINTESTINAL TUBE INSERTION 70 0.0280
56 PSEUDOMONAS TEST POSITIVE 22 0.0269
57 PANCREATITIS NECROTISING 60 0.0261
58 BILE DUCT CANCER 31 0.0261
59 HYPOVITAMINOSIS 33 0.0249
60 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 23 0.0248
61 FORCED EXPIRATORY VOLUME DECREASED 69 0.0243
62 BILE DUCT STENOSIS 28 0.0234
63 BRONCHIAL SECRETION RETENTION 29 0.0228
64 ADRENAL SUPPRESSION 19 0.0225
65 CHOLECYSTECTOMY 255 0.0223
66 GASTRIC BYPASS 48 0.0220
67 OBSTRUCTION GASTRIC 28 0.0218
68 SINUS OPERATION 50 0.0210
69 MALNUTRITION 229 0.0204
70 PSEUDOMONAS INFECTION 170 0.0198
71 MEDICAL PROCEDURE 32 0.0192
72 GALLBLADDER OPERATION 76 0.0188
73 UNDERWEIGHT 37 0.0187
74 GASTROSTOMY 29 0.0187
75 INTRA-ABDOMINAL FLUID COLLECTION 33 0.0184
76 INTESTINAL OPERATION 29 0.0183
77 HEPATIC INFECTION 23 0.0180
78 ABDOMINAL OPERATION 23 0.0177
79 BILE DUCT OBSTRUCTION 33 0.0174
80 RADIOTHERAPY 33 0.0172
81 FOOD INTOLERANCE 61 0.0166
82 FLATULENCE 934 0.0165
83 CENTRAL VENOUS CATHETERISATION 49 0.0162
84 PANCREATIC CARCINOMA STAGE IV 51 0.0162
85 BILIARY TRACT DISORDER 22 0.0159
86 BILIARY DILATATION 23 0.0156
87 PNEUMONIA PSEUDOMONAL 24 0.0156
88 NEUROENDOCRINE TUMOUR 22 0.0155
89 HOSPICE CARE 146 0.0148
90 PANCREATITIS 781 0.0148
91 ANAL INCONTINENCE 126 0.0140
92 PNEUMONIA STAPHYLOCOCCAL 27 0.0137
93 INCISIONAL HERNIA 19 0.0137
94 PANCREATITIS ACUTE 306 0.0136
95 FAECES PALE 30 0.0135
96 WEIGHT ABNORMAL 32 0.0133
97 GASTROINTESTINAL OBSTRUCTION 32 0.0133
98 PRODUCT STORAGE ISSUE 49 0.0129
99 INCREASED BRONCHIAL SECRETION 33 0.0129
100 BILE DUCT STONE 41 0.0129
101 PULMONARY FUNCTION TEST ABNORMAL 20 0.0128
102 VASCULAR DEVICE INFECTION 58 0.0128
103 LIVER ABSCESS 41 0.0126
104 FAECES HARD 49 0.0126
105 HEPATIC NEOPLASM 41 0.0126
106 RHINOVIRUS INFECTION 48 0.0123
107 CHOLANGITIS 76 0.0122
108 HYPOPHAGIA 311 0.0122
109 DYSCHEZIA 37 0.0121
110 FEEDING DISORDER 242 0.0119
111 VOLVULUS 27 0.0114
112 TONSILLECTOMY 19 0.0114
113 COLONOSCOPY 25 0.0113
114 PRODUCT LOT NUMBER ISSUE 25 0.0113
115 PORTAL VEIN THROMBOSIS 36 0.0111
116 TYPE 1 DIABETES MELLITUS 67 0.0111
117 STENT PLACEMENT 89 0.0110
118 RECURRENT CANCER 45 0.0110
119 APPENDICECTOMY 39 0.0109
120 DEFAECATION URGENCY 74 0.0106
121 STAPHYLOCOCCUS TEST POSITIVE 22 0.0104
122 SPINAL OPERATION 128 0.0104
123 HERNIA 200 0.0103
124 NECK SURGERY 24 0.0103
125 SPUTUM DISCOLOURED 93 0.0098
126 SURGERY 568 0.0097
127 HAEMOPTYSIS 268 0.0096
128 METASTATIC NEOPLASM 41 0.0095
129 ABDOMINAL ADHESIONS 30 0.0095
130 RESPIRATORY SYMPTOM 27 0.0095
131 PRODUCT SIZE ISSUE 50 0.0093
132 ABDOMINAL DISTENSION 962 0.0092
133 PRODUCT DISPENSING ISSUE 39 0.0091
134 BRONCHIECTASIS 61 0.0090
135 OBSTRUCTION 36 0.0090
136 INTESTINAL OBSTRUCTION 339 0.0090
137 FREQUENT BOWEL MOVEMENTS 239 0.0088
138 GASTROINTESTINAL MOTILITY DISORDER 47 0.0088
139 FAILURE TO THRIVE 45 0.0087
140 RASH MORBILLIFORM 24 0.0086
141 HAEMOLYTIC URAEMIC SYNDROME 20 0.0086
142 BOWEL MOVEMENT IRREGULARITY 66 0.0086
143 FLUID INTAKE REDUCED 43 0.0086
144 EMERGENCY CARE 26 0.0086
145 POLYP 56 0.0085
146 SMALL INTESTINAL OBSTRUCTION 105 0.0085
147 DISTURBANCE IN SOCIAL BEHAVIOUR 20 0.0085
148 ABDOMINAL RIGIDITY 23 0.0085
149 SHOULDER OPERATION 36 0.0084
150 IMPAIRED GASTRIC EMPTYING 114 0.0084
151 RESPIRATION ABNORMAL 56 0.0081
152 BLOOD MAGNESIUM DECREASED 70 0.0081
153 LUNG INFECTION 126 0.0081
154 ESCHERICHIA BACTERAEMIA 19 0.0081
155 TRANSPLANT 19 0.0080
156 LUNG OPACITY 21 0.0080
157 PROTEIN TOTAL DECREASED 30 0.0080
158 LIPASE INCREASED 60 0.0078
159 LACTOSE INTOLERANCE 20 0.0078
160 ABNORMAL LOSS OF WEIGHT 53 0.0078
161 COLECTOMY 43 0.0076
162 IRON DEFICIENCY 34 0.0076
163 GASTROINTESTINAL PAIN 83 0.0075
164 SYMPTOM RECURRENCE 45 0.0075
165 FAECES SOFT 54 0.0074
166 HEPATIC LESION 32 0.0074
167 DIVERTICULUM INTESTINAL 32 0.0073
168 NEOPLASM 84 0.0073
169 STAPHYLOCOCCAL SEPSIS 36 0.0073
170 NEOPLASM MALIGNANT 485 0.0073
171 GASTROINTESTINAL SOUNDS ABNORMAL 36 0.0073
172 ESCHERICHIA SEPSIS 21 0.0072
173 FAECES DISCOLOURED 157 0.0072
174 DISEASE COMPLICATION 33 0.0072
175 RENAL TRANSPLANT 26 0.0072
176 COLITIS MICROSCOPIC 34 0.0072
177 EYE OPERATION 33 0.0072
178 LIMB OPERATION 34 0.0071
179 LARGE INTESTINE POLYP 49 0.0071
180 CACHEXIA 36 0.0070
181 PRODUCT USE COMPLAINT 110 0.0070
182 GLUCOSE TOLERANCE IMPAIRED 41 0.0069
183 BRAIN FOG 108 0.0069
184 BILIARY COLIC 20 0.0069
185 FOOD ALLERGY 53 0.0069
186 ABDOMINAL PAIN 1586 0.0068
187 HOSPITALISATION 1036 0.0067
188 WEIGHT DECREASED 1879 0.0067
189 REHABILITATION THERAPY 26 0.0067
190 BLOOD CREATININE DECREASED 21 0.0067
191 RESPIRATORY SYNCYTIAL VIRUS INFECTION 58 0.0067
192 LIVER TRANSPLANT 24 0.0066
193 ABDOMINAL HERNIA 30 0.0066
194 THROMBOCYTOSIS 24 0.0065
195 PRODUCT ADMINISTRATION ERROR 132 0.0065
196 DYSPEPSIA 638 0.0065
197 BLOOD ALKALINE PHOSPHATASE INCREASED 161 0.0065
198 ABDOMINAL PAIN UPPER 1332 0.0065
199 HYSTERECTOMY 56 0.0065
200 HEPATIC FIBROSIS 22 0.0064
201 CHRONIC SINUSITIS 24 0.0064
202 PROSTATOMEGALY 25 0.0064
203 PRODUCT PHYSICAL ISSUE 127 0.0063
204 GENERAL SYMPTOM 47 0.0063
205 HIATUS HERNIA 81 0.0062
206 EXERCISE TOLERANCE DECREASED 36 0.0062
207 JAUNDICE CHOLESTATIC 22 0.0062
208 PRODUCT DISPENSING ERROR 135 0.0062
209 PORTAL HYPERTENSION 19 0.0062
210 DIABETES MELLITUS 469 0.0061
211 VITAMIN D DEFICIENCY 60 0.0061
212 CERVICAL VERTEBRAL FRACTURE 21 0.0061
213 SPINAL STENOSIS 25 0.0061
214 CARDIAC OPERATION 52 0.0060
215 GASTROINTESTINAL DISORDER 540 0.0060
216 PNEUMOTHORAX 95 0.0060
217 DIARRHOEA 3866 0.0060
218 CLOSTRIDIUM DIFFICILE INFECTION 129 0.0059
219 NASAL POLYPS 29 0.0059
220 VITAMIN D DECREASED 50 0.0058
221 ERUCTATION 113 0.0058
222 PRODUCT TASTE ABNORMAL 79 0.0058
223 PRODUCTIVE COUGH 277 0.0058
224 HEPATIC CIRRHOSIS 109 0.0058
225 SOCIAL PROBLEM 24 0.0058
226 PRODUCT ODOUR ABNORMAL 60 0.0057
227 AMYLASE INCREASED 21 0.0057
228 BLOOD IRON DECREASED 67 0.0056
229 PULMONARY HAEMORRHAGE 43 0.0055
230 GALLBLADDER DISORDER 98 0.0055
231 FAECALOMA 30 0.0055
232 HYPERTRANSAMINASAEMIA 38 0.0055
233 TERMINAL STATE 36 0.0054
234 HIP FRACTURE 172 0.0053
235 TEARFULNESS 23 0.0053
236 THROAT CLEARING 20 0.0053
237 CORONARY ARTERIAL STENT INSERTION 27 0.0053
238 BLOOD POTASSIUM DECREASED 160 0.0053
239 PARANASAL SINUS HYPERSECRETION 20 0.0052
240 GASTRIC INFECTION 20 0.0052
241 ATTENTION DEFICIT HYPERACTIVITY DISORDER 22 0.0052
242 INTESTINAL RESECTION 28 0.0052
243 ELECTROLYTE IMBALANCE 60 0.0052
244 UNEVALUABLE EVENT 386 0.0051
245 NEPHROLITHIASIS 234 0.0051
246 WEIGHT FLUCTUATION 53 0.0051
247 BLOOD GLUCOSE FLUCTUATION 55 0.0050
248 COLITIS 190 0.0050
249 METASTASES TO LIVER 88 0.0050
250 DEVICE OCCLUSION 70 0.0050
251 LUNG DISORDER 242 0.0049
252 CONSTIPATION 1072 0.0049
253 CONCUSSION 38 0.0049
254 ENTEROCOLITIS 28 0.0048
255 FOOT OPERATION 24 0.0048
256 VIRAL INFECTION 161 0.0048
257 ASCITES 142 0.0048
258 ILLNESS 497 0.0048
259 CHOLELITHIASIS 158 0.0048
260 PNEUMONIA BACTERIAL 44 0.0048
261 BACTERIAL INFECTION 89 0.0048
262 HYPERPHAGIA 19 0.0048
263 NEPHROGENIC ANAEMIA 22 0.0047
264 ESCHERICHIA INFECTION 39 0.0047
265 DEHYDRATION 631 0.0047
266 GASTROINTESTINAL INFLAMMATION 37 0.0047
267 LIVER FUNCTION TEST INCREASED 101 0.0047
268 POST PROCEDURAL COMPLICATION 90 0.0047
269 JAUNDICE 126 0.0047
270 TRIGGER FINGER 19 0.0046
271 HEPATIC ENCEPHALOPATHY 43 0.0046
272 INGUINAL HERNIA 28 0.0046
273 KNEE OPERATION 45 0.0046
274 INFECTION 661 0.0046
275 PROCEDURAL COMPLICATION 35 0.0046
276 STAPHYLOCOCCAL INFECTION 150 0.0045
277 RENAL CYST 36 0.0045
278 RENAL FUNCTION TEST ABNORMAL 21 0.0045
279 OBSTRUCTIVE AIRWAYS DISORDER 50 0.0045
280 IRRITABLE BOWEL SYNDROME 96 0.0045
281 SECRETION DISCHARGE 56 0.0045
282 FRUSTRATION TOLERANCE DECREASED 36 0.0045
283 IRON DEFICIENCY ANAEMIA 41 0.0044
284 BLOOD GLUCOSE ABNORMAL 82 0.0044
285 POST PROCEDURAL INFECTION 36 0.0044
286 HYPOKALAEMIA 203 0.0044
287 TUMOUR MARKER INCREASED 21 0.0044
288 PULMONARY MASS 65 0.0044
289 KNEE ARTHROPLASTY 91 0.0043
290 SKIN LACERATION 47 0.0043
291 AUTOIMMUNE DISORDER 42 0.0043
292 WRONG PRODUCT ADMINISTERED 29 0.0043
293 GASTROENTERITIS VIRAL 77 0.0043
294 HIP SURGERY 23 0.0042
295 SINUS DISORDER 84 0.0042
296 MUCOUS STOOLS 21 0.0042
297 HUNGER 59 0.0042
298 CHOLESTASIS 81 0.0042
299 VIRAL UPPER RESPIRATORY TRACT INFECTION 20 0.0042
300 HAEMORRHOIDS 82 0.0042
301 HYPOMAGNESAEMIA 58 0.0042
302 BLOOD ALBUMIN DECREASED 33 0.0042
303 RESPIRATORY TRACT CONGESTION 66 0.0041
304 SEPSIS 463 0.0041
305 GASTROINTESTINAL INFECTION 37 0.0041
306 AMMONIA INCREASED 21 0.0041
307 PELVIC FRACTURE 32 0.0041
308 BLOOD SODIUM DECREASED 77 0.0041
309 DIVERTICULUM 29 0.0041
310 UMBILICAL HERNIA 19 0.0041
311 HIP ARTHROPLASTY 62 0.0040
312 GAMMA-GLUTAMYLTRANSFERASE INCREASED 89 0.0040
313 HYPOCALCAEMIA 76 0.0040
314 GOUT 72 0.0040
315 RALES 23 0.0040
316 ARTERIAL OCCLUSIVE DISEASE 31 0.0039
317 MACULAR DEGENERATION 47 0.0039
318 PHARYNGITIS STREPTOCOCCAL 42 0.0039
319 ILEUS 48 0.0039
320 CATARACT 229 0.0038
321 GASTRITIS 101 0.0038
322 DIABETIC NEUROPATHY 19 0.0038
323 INTESTINAL PERFORATION 43 0.0038
324 BLOOD BILIRUBIN INCREASED 103 0.0038
325 GENERALISED OEDEMA 47 0.0038
326 ORAL CANDIDIASIS 50 0.0038
327 CYST 47 0.0038
328 CLOSTRIDIUM DIFFICILE COLITIS 40 0.0038
329 HEPATIC STEATOSIS 70 0.0038
330 SPINAL OSTEOARTHRITIS 33 0.0038
331 BLOOD GLUCOSE DECREASED 180 0.0037
332 RESPIRATORY DISORDER 112 0.0037
333 RIB FRACTURE 77 0.0037
334 HEPATOCELLULAR INJURY 53 0.0037
335 HYPOALBUMINAEMIA 29 0.0037
336 HYPOGLYCAEMIA 180 0.0037
337 ULCER 59 0.0037
338 GASTROOESOPHAGEAL REFLUX DISEASE 297 0.0037
339 COELIAC DISEASE 36 0.0037
340 SARS-COV-2 TEST POSITIVE 48 0.0036
341 APPETITE DISORDER 24 0.0036
342 ENTERITIS 23 0.0036
343 ABSCESS 57 0.0036
344 MULTIPLE ALLERGIES 28 0.0036
345 UPPER LIMB FRACTURE 71 0.0036
346 GASTRIC DISORDER 122 0.0036
347 SEASONAL ALLERGY 50 0.0035
348 INSURANCE ISSUE 54 0.0035
349 CHOLECYSTITIS 42 0.0035
350 CEREBRAL DISORDER 26 0.0035
351 BEHAVIOUR DISORDER 19 0.0035
352 WRIST FRACTURE 42 0.0035
353 BACK INJURY 38 0.0035
354 HYPERGLYCAEMIA 127 0.0035
355 GASTRIC ULCER 66 0.0035
356 COVID-19 PNEUMONIA 41 0.0035
357 INFLUENZA 387 0.0035
358 COUGH 972 0.0035
359 PROCEDURAL PAIN 96 0.0035
360 MENISCUS INJURY 21 0.0034
361 UPPER-AIRWAY COUGH SYNDROME 28 0.0034
362 ABDOMINAL DISCOMFORT 570 0.0034
363 GASTRIC HAEMORRHAGE 39 0.0034
364 BLOOD POTASSIUM INCREASED 55 0.0034
365 DIALYSIS 48 0.0034
366 PNEUMONIA 1093 0.0034
367 ARTHROPOD BITE 25 0.0034
368 PRE-EXISTING CONDITION IMPROVED 21 0.0034
369 CHOLECYSTITIS ACUTE 19 0.0033
370 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 161 0.0033
371 BODY TEMPERATURE INCREASED 68 0.0033
372 RETCHING 71 0.0033
373 LYMPHOEDEMA 23 0.0033
374 INTERNAL HAEMORRHAGE 38 0.0033
375 ALANINE AMINOTRANSFERASE INCREASED 204 0.0033
376 POOR QUALITY PRODUCT ADMINISTERED 35 0.0033
377 HAEMATEMESIS 84 0.0033
378 TASTE DISORDER 67 0.0033
379 INTENTIONAL PRODUCT MISUSE 289 0.0033
380 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 56 0.0033
381 APHONIA 46 0.0033
382 DIVERTICULITIS 91 0.0033
383 DECREASED APPETITE 762 0.0033
384 PROCTALGIA 21 0.0033
385 HEPATIC CANCER 78 0.0032
386 MUSCLE ATROPHY 41 0.0032
387 TOXIC EPIDERMAL NECROLYSIS 49 0.0032
388 INCONTINENCE 34 0.0032
389 ADRENAL INSUFFICIENCY 39 0.0032
390 ROTATOR CUFF SYNDROME 41 0.0032
391 CARDIAC PACEMAKER INSERTION 19 0.0032
392 EXOSTOSIS 29 0.0032
393 VOMITING 1493 0.0032
394 LARGE INTESTINE PERFORATION 22 0.0032
395 BRAIN NEOPLASM 29 0.0032
396 IMMUNODEFICIENCY 47 0.0031
397 EATING DISORDER 67 0.0031
398 EOSINOPHIL COUNT INCREASED 26 0.0031
399 BACTERAEMIA 37 0.0031
400 HYPOPHOSPHATAEMIA 23 0.0031
401 METASTASES TO LYMPH NODES 21 0.0031
402 ORTHOSTATIC HYPOTENSION 54 0.0031
403 CHROMATURIA 70 0.0031
404 SCAR 53 0.0031
405 ASPARTATE AMINOTRANSFERASE INCREASED 164 0.0031
406 DISABILITY 61 0.0031
407 TREATMENT NONCOMPLIANCE 168 0.0031
408 BLOOD TEST ABNORMAL 43 0.0031
409 HYPERTENSIVE CRISIS 34 0.0031
410 THYROID DISORDER 47 0.0030
411 SPINAL FRACTURE 61 0.0030
412 LIGAMENT SPRAIN 30 0.0030
413 PULMONARY THROMBOSIS 33 0.0030
414 TROPONIN INCREASED 23 0.0030
415 END STAGE RENAL DISEASE 55 0.0030
416 MYOPATHY 26 0.0030
417 HEPATIC ENZYME INCREASED 205 0.0030
418 CARDIAC FAILURE ACUTE 20 0.0030
419 PSYCHIATRIC SYMPTOM 22 0.0030
420 HAND FRACTURE 21 0.0030
421 CANDIDA INFECTION 50 0.0030
422 DYSPHONIA 173 0.0030
423 LIVER DISORDER 131 0.0030
424 NEUTROPENIC SEPSIS 21 0.0029
425 DIABETES MELLITUS INADEQUATE CONTROL 52 0.0029
426 ACCIDENT 35 0.0029
427 ASPIRATION 32 0.0029
428 FUNGAL INFECTION 97 0.0029
429 HYPERBILIRUBINAEMIA 30 0.0029
430 NEPHROPATHY 27 0.0029
431 EMBOLISM 24 0.0029
432 DYSPHAGIA 273 0.0029
433 BRONCHOSPASM 41 0.0029
434 THROMBOTIC MICROANGIOPATHY 28 0.0029
435 CHRONIC KIDNEY DISEASE 218 0.0029
436 DEAFNESS 75 0.0029
437 ASTHENIA 1075 0.0029
438 DEVICE RELATED INFECTION 44 0.0029
439 DRY THROAT 29 0.0029
440 SPINAL DISORDER 27 0.0028
441 HYPERLIPIDAEMIA 34 0.0028
442 BODY TEMPERATURE DECREASED 28 0.0028
443 MUSCULOSKELETAL CHEST PAIN 44 0.0028
444 SPLENOMEGALY 33 0.0028
445 WHEEZING 167 0.0028
446 GAIT INABILITY 94 0.0028
447 GENERAL PHYSICAL CONDITION ABNORMAL 19 0.0028
448 AFFECTIVE DISORDER 22 0.0028
449 ATELECTASIS 27 0.0028
450 INTERVERTEBRAL DISC PROTRUSION 61 0.0028
451 PAROSMIA 21 0.0028
452 HEAD INJURY 88 0.0028
453 TYPE 2 DIABETES MELLITUS 93 0.0028
454 ACUTE KIDNEY INJURY 422 0.0028
455 ROAD TRAFFIC ACCIDENT 115 0.0027
456 MALAISE 1205 0.0027
457 FALL 913 0.0027
458 CYSTITIS 87 0.0027
459 PULMONARY CONGESTION 36 0.0027
460 LYMPHOMA 42 0.0027
461 BLOOD THYROID STIMULATING HORMONE INCREASED 25 0.0027
462 TEMPERATURE INTOLERANCE 28 0.0027
463 CHEST DISCOMFORT 277 0.0027
464 OXYGEN SATURATION DECREASED 152 0.0027
465 KIDNEY INFECTION 53 0.0027
466 OSTEOPOROSIS 111 0.0027
467 NERVE INJURY 30 0.0027
468 DUODENAL ULCER 19 0.0027
469 HYPERKALAEMIA 94 0.0027
470 HAEMATOCRIT DECREASED 53 0.0027
471 SINUS CONGESTION 36 0.0027
472 ORAL DISCOMFORT 37 0.0027
473 TRANSAMINASES INCREASED 59 0.0027
474 HYPERSOMNIA 76 0.0026
475 OSTEOPENIA 40 0.0026
476 THIRST 47 0.0026
477 AORTIC ANEURYSM 20 0.0026
478 BREAST PAIN 28 0.0026
479 CORONARY ARTERY OCCLUSION 36 0.0026
480 RED BLOOD CELL COUNT DECREASED 75 0.0026
481 COMPLICATION ASSOCIATED WITH DEVICE 38 0.0026
482 SINUSITIS 268 0.0026
483 LOWER LIMB FRACTURE 50 0.0026
484 UROSEPSIS 24 0.0026
485 NERVE COMPRESSION 24 0.0026
486 PERSONALITY CHANGE 24 0.0026
487 BLOOD CALCIUM DECREASED 29 0.0026
488 DEPRESSED MOOD 136 0.0026
489 INCREASED APPETITE 49 0.0026
490 INTENTIONAL DOSE OMISSION 73 0.0026
491 EAR INFECTION 68 0.0026
492 POOR QUALITY SLEEP 55 0.0026
493 PLEURAL EFFUSION 155 0.0025
494 ACUTE RESPIRATORY FAILURE 49 0.0025
495 LIVER FUNCTION TEST ABNORMAL 74 0.0025
496 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 181 0.0025
497 HYDRONEPHROSIS 19 0.0025
498 BLOOD PRESSURE ABNORMAL 50 0.0025
499 URINARY TRACT INFECTION 428 0.0025
500 SKIN CANCER 54 0.0025
501 GENERAL PHYSICAL HEALTH DETERIORATION 290 0.0025
502 LIMB INJURY 68 0.0025
503 HEPATIC FAILURE 75 0.0025
504 THROMBOSIS 200 0.0025
505 WEIGHT INCREASED 556 0.0025
506 PRODUCT DISTRIBUTION ISSUE 23 0.0025
507 EMPHYSEMA 25 0.0025
508 PRODUCT DOSE OMISSION IN ERROR 70 0.0025
509 UPPER RESPIRATORY TRACT INFECTION 114 0.0025
510 MELAENA 54 0.0025
511 BLOOD UREA INCREASED 41 0.0024
512 LEUKAEMIA 23 0.0024
513 THERAPEUTIC PRODUCT EFFECT DECREASED 109 0.0024
514 BODY HEIGHT DECREASED 26 0.0024
515 MUSCLE STRAIN 21 0.0024
516 NAUSEA 1912 0.0024
517 RHINORRHOEA 156 0.0024
518 DEATH 2066 0.0024
519 ANKLE FRACTURE 37 0.0024
520 MITRAL VALVE INCOMPETENCE 27 0.0024
521 DERMATITIS ALLERGIC 30 0.0024
522 RESPIRATORY TRACT INFECTION 62 0.0024
523 LEUKOCYTOSIS 43 0.0024
524 ORAL PAIN 53 0.0024
525 SLEEP DISORDER 167 0.0024
526 LETHARGY 136 0.0024
527 LUNG NEOPLASM MALIGNANT 97 0.0024
528 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 123 0.0024
529 DENTAL CARIES 26 0.0023
530 SEPTIC SHOCK 102 0.0023
531 HEPATOMEGALY 23 0.0023
532 INITIAL INSOMNIA 24 0.0023
533 PERICARDIAL EFFUSION 54 0.0023
534 HELICOBACTER INFECTION 24 0.0023
535 TOOTH EXTRACTION 29 0.0023
536 BACK PAIN 541 0.0023
537 OSTEOARTHRITIS 98 0.0023
538 SPINAL PAIN 27 0.0023
539 NEUROPATHY PERIPHERAL 219 0.0023
540 DRUG LEVEL INCREASED 38 0.0023
541 ABDOMINAL PAIN LOWER 58 0.0023
542 CARPAL TUNNEL SYNDROME 32 0.0023
543 BLOOD CALCIUM INCREASED 20 0.0023
544 GROIN PAIN 20 0.0023
545 HYPOACUSIS 98 0.0023
546 FULL BLOOD COUNT ABNORMAL 24 0.0023
547 FOOT FRACTURE 43 0.0023
548 AGRANULOCYTOSIS 42 0.0023
549 COVID-19 396 0.0023
550 SYSTEMIC LUPUS ERYTHEMATOSUS 80 0.0023
551 RASH MACULO-PAPULAR 50 0.0022
552 OROPHARYNGEAL PAIN 208 0.0022
553 HYPOXIA 79 0.0022
554 FLANK PAIN 21 0.0022
555 RECTAL HAEMORRHAGE 96 0.0022
556 ANAEMIA 423 0.0022
557 PYREXIA 767 0.0022
558 COLON CANCER 33 0.0022
559 NASOPHARYNGITIS 408 0.0022
560 INTERNATIONAL NORMALISED RATIO INCREASED 63 0.0022
561 RENAL FAILURE 293 0.0022
562 PAIN 1351 0.0022
563 LOSS OF CONSCIOUSNESS 281 0.0022
564 LOCALISED INFECTION 53 0.0022
565 CELLULITIS 110 0.0022
566 PHARYNGITIS 27 0.0022
567 RESPIRATORY DISTRESS 60 0.0022
568 RESPIRATORY FAILURE 158 0.0022
569 CEREBROVASCULAR ACCIDENT 367 0.0022
570 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
571 METABOLIC ACIDOSIS 69 0.0022
572 FATIGUE 1678 0.0022
573 MUSCULOSKELETAL DISORDER 41 0.0022
574 BACK DISORDER 35 0.0022
575 PERIPHERAL SWELLING 330 0.0021
576 NOCTURIA 26 0.0021
577 DIARRHOEA HAEMORRHAGIC 20 0.0021
578 DYSPNOEA 1210 0.0021
579 FEMUR FRACTURE 66 0.0021
580 ATRIAL FIBRILLATION 207 0.0021
581 RENAL DISORDER 99 0.0021
582 LYMPHOPENIA 30 0.0021
583 PERIPHERAL COLDNESS 29 0.0021
584 LOWER RESPIRATORY TRACT INFECTION 96 0.0021
585 STOMATITIS 128 0.0021
586 OESOPHAGITIS 23 0.0021
587 PRODUCT PACKAGING ISSUE 20 0.0021
588 TRANSFUSION 22 0.0021
589 SLEEP APNOEA SYNDROME 40 0.0021
590 BLOOD PRESSURE DECREASED 139 0.0021
591 MENTAL DISORDER 91 0.0021
592 DISCOMFORT 127 0.0021
593 FEBRILE NEUTROPENIA 138 0.0021
594 EXPIRED PRODUCT ADMINISTERED 69 0.0021
595 FOOT DEFORMITY 23 0.0021
596 DIZZINESS POSTURAL 20 0.0021
597 FRACTURE 39 0.0021
598 GASTROINTESTINAL HAEMORRHAGE 172 0.0021
599 CONJUNCTIVITIS 38 0.0020
600 ARTHRITIS 161 0.0020
601 DYSPNOEA EXERTIONAL 77 0.0020
602 PHARYNGEAL SWELLING 20 0.0020
603 COLD SWEAT 36 0.0020
604 HYPONATRAEMIA 115 0.0020
605 DIABETIC KETOACIDOSIS 49 0.0020
606 PANCYTOPENIA 114 0.0020
607 MIDDLE INSOMNIA 38 0.0020
608 OEDEMA PERIPHERAL 248 0.0020
609 APPENDICITIS 19 0.0020
610 ARTERIOSCLEROSIS 19 0.0020
611 SQUAMOUS CELL CARCINOMA 19 0.0020
612 CHEST PAIN 373 0.0020
613 JOINT INJURY 43 0.0020
614 HAEMATOCHEZIA 111 0.0020
615 DYSURIA 74 0.0020
616 MEMORY IMPAIRMENT 275 0.0020
617 METASTASES TO LUNG 23 0.0020
618 MUCOSAL INFLAMMATION 52 0.0020
619 GLYCOSYLATED HAEMOGLOBIN INCREASED 50 0.0020
620 BLOOD GLUCOSE INCREASED 373 0.0020
621 PRODUCT PRESCRIBING ERROR 47 0.0020
622 HYPOTHYROIDISM 63 0.0020
623 HAEMATOMA 51 0.0020
624 SNEEZING 44 0.0020
625 UPPER GASTROINTESTINAL HAEMORRHAGE 33 0.0020
626 FISTULA 22 0.0020
627 WHITE BLOOD CELL COUNT INCREASED 75 0.0020
628 BLOOD URINE PRESENT 37 0.0019
629 THROAT IRRITATION 87 0.0019
630 OEDEMA 105 0.0019
631 OSTEOMYELITIS 35 0.0019
632 HEAD DISCOMFORT 34 0.0019
633 BEDRIDDEN 25 0.0019
634 PULMONARY OEDEMA 85 0.0019
635 DEMENTIA 53 0.0019
636 THROMBOCYTOPENIA 212 0.0019
637 BRONCHITIS 140 0.0019
638 MUSCLE SPASMS 347 0.0019
639 POST PROCEDURAL HAEMORRHAGE 22 0.0019
640 NASAL CONGESTION 111 0.0019
641 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 44 0.0019
642 RENAL PAIN 20 0.0019
643 PNEUMONITIS 51 0.0019
644 GLOMERULAR FILTRATION RATE DECREASED 23 0.0019
645 MOOD ALTERED 51 0.0019
646 HYPERTHYROIDISM 27 0.0019
647 SLUGGISHNESS 19 0.0019
648 NIGHT SWEATS 60 0.0019
649 PRODUCT STORAGE ERROR 163 0.0019
650 ADVERSE DRUG REACTION 167 0.0019
651 NEUTROPHIL COUNT INCREASED 19 0.0019
652 DECREASED ACTIVITY 20 0.0019
653 HEART RATE DECREASED 65 0.0018
654 BLOOD PRESSURE SYSTOLIC INCREASED 36 0.0018
655 AGEUSIA 46 0.0018
656 PNEUMONIA ASPIRATION 46 0.0018
657 NEOPLASM PROGRESSION 64 0.0018
658 TRANSIENT ISCHAEMIC ATTACK 62 0.0018
659 LYMPHADENOPATHY 65 0.0018
660 CHILLS 215 0.0018
661 HAEMOGLOBIN DECREASED 188 0.0018
662 FLUID RETENTION 93 0.0018
663 DEPRESSION 416 0.0018
664 PRODUCT DOSE OMISSION 119 0.0018
665 IMMUNE SYSTEM DISORDER 24 0.0018
666 UNRESPONSIVE TO STIMULI 47 0.0018
667 NEURALGIA 44 0.0018
668 JOINT DISLOCATION 19 0.0018
669 ABORTION SPONTANEOUS 72 0.0018
670 ANXIETY 511 0.0018
671 BASAL CELL CARCINOMA 28 0.0018
672 ANAPHYLACTIC REACTION 99 0.0018
673 MASS 25 0.0018
674 APHASIA 54 0.0018
675 MALIGNANT NEOPLASM PROGRESSION 182 0.0018
676 THROAT TIGHTNESS 48 0.0018
677 MIGRAINE 169 0.0018
678 HYPERTENSION 375 0.0018
679 CONDITION AGGRAVATED 538 0.0018
680 LABORATORY TEST ABNORMAL 52 0.0018
681 SCIATICA 28 0.0018
682 DYSSTASIA 51 0.0017
683 CHOKING 34 0.0017
684 BLINDNESS 71 0.0017
685 IMPAIRED QUALITY OF LIFE 25 0.0017
686 DIZZINESS 867 0.0017
687 FULL BLOOD COUNT DECREASED 35 0.0017
688 PARAESTHESIA ORAL 25 0.0017
689 POLLAKIURIA 72 0.0017
690 TOOTH FRACTURE 19 0.0017
691 CARDIAC DISORDER 161 0.0017
692 NECK PAIN 96 0.0017
693 DISORIENTATION 68 0.0017
694 QUALITY OF LIFE DECREASED 23 0.0017
695 MOBILITY DECREASED 123 0.0017
696 HYPERCALCAEMIA 21 0.0017
697 MOOD SWINGS 54 0.0017
698 SKIN INFECTION 19 0.0017
699 EMOTIONAL DISORDER 52 0.0017
700 INSOMNIA 449 0.0017
701 FEELING ABNORMAL 401 0.0017
702 DRUG INTERACTION 265 0.0017
703 SYNCOPE 167 0.0017
704 PULMONARY FIBROSIS 32 0.0017
705 MICTURITION URGENCY 19 0.0017
706 FEELING COLD 46 0.0017
707 HEPATIC CYTOLYSIS 21 0.0016
708 BONE DISORDER 30 0.0016
709 APATHY 24 0.0016
710 IMPAIRED HEALING 54 0.0016
711 GASTROENTERITIS 24 0.0016
712 BALANCE DISORDER 142 0.0016
713 SPEECH DISORDER 86 0.0016
714 VERTIGO 100 0.0016
715 LYMPHOCYTE COUNT DECREASED 29 0.0016
716 BONE PAIN 96 0.0016
717 GENERALISED TONIC-CLONIC SEIZURE 27 0.0016
718 INFLAMMATION 84 0.0016
719 MULTIPLE ORGAN DYSFUNCTION SYNDROME 46 0.0016
720 CONFUSIONAL STATE 261 0.0016
721 RESTLESSNESS 59 0.0016
722 RENAL FAILURE ACUTE 68 0.0016
723 HEPATITIS 41 0.0016
724 DYSGEUSIA 119 0.0016
725 ASTHMA 181 0.0016
726 HEADACHE 1003 0.0016
727 AMNESIA 104 0.0016
728 ANGER 54 0.0016
729 EAR PAIN 31 0.0016
730 MYOCLONUS 19 0.0016
731 URINARY INCONTINENCE 47 0.0016
732 PANIC ATTACK 57 0.0016
733 PRESYNCOPE 38 0.0016
734 BLINDNESS UNILATERAL 22 0.0016
735 ELECTROCARDIOGRAM QT PROLONGED 56 0.0016
736 ANOREXIA 20 0.0016
737 NERVOUSNESS 81 0.0015
738 EXPOSURE DURING PREGNANCY 96 0.0015
739 RENAL IMPAIRMENT 129 0.0015
740 LIP SWELLING 51 0.0015
741 MULTIPLE FRACTURES 25 0.0015
742 PHOTOSENSITIVITY REACTION 25 0.0015
743 EPISTAXIS 113 0.0015
744 HYPOTENSION 303 0.0015
745 CEREBRAL HAEMORRHAGE 54 0.0015
746 GLAUCOMA 29 0.0015
747 GASTRIC CANCER 38 0.0015
748 ILL-DEFINED DISORDER 91 0.0015
749 BLOOD PRESSURE INCREASED 228 0.0015
750 MENTAL IMPAIRMENT 36 0.0015
751 HEART RATE INCREASED 147 0.0015
752 PAIN IN JAW 42 0.0015
753 RENAL INJURY 44 0.0015
754 SEIZURE 171 0.0015
755 ARTHRALGIA 613 0.0015
756 SWOLLEN TONGUE 46 0.0015
757 DELIRIUM 51 0.0015
758 DRUG-INDUCED LIVER INJURY 46 0.0015
759 IRRITABILITY 88 0.0015
760 PARANOIA 25 0.0014
761 THINKING ABNORMAL 27 0.0014
762 HERPES ZOSTER 83 0.0014
763 HYPERHIDROSIS 186 0.0014
764 MUSCULAR WEAKNESS 164 0.0014
765 DRY EYE 72 0.0014
766 SUICIDAL IDEATION 132 0.0014
767 INCORRECT DOSE ADMINISTERED 327 0.0014
768 SKIN ULCER 37 0.0014
769 PHARYNGEAL OEDEMA 22 0.0014
770 PAIN IN EXTREMITY 421 0.0014
771 COMA 68 0.0014
772 MATERNAL EXPOSURE DURING PREGNANCY 127 0.0014
773 BLOOD CREATINE PHOSPHOKINASE INCREASED 41 0.0014
774 LACRIMATION INCREASED 43 0.0014
775 THERAPY CESSATION 73 0.0014
776 CARDIAC FAILURE 114 0.0014
777 SKIN REACTION 20 0.0014
778 NIGHTMARE 49 0.0014
779 BLOOD TRIGLYCERIDES INCREASED 25 0.0014
780 BRADYCARDIA 75 0.0014
781 FEAR 38 0.0014
782 JOINT STIFFNESS 37 0.0014
783 SKIN DISORDER 47 0.0014
784 CONTUSION 135 0.0014
785 CYANOSIS 22 0.0014
786 FIBROMYALGIA 34 0.0014
787 TACHYPNOEA 19 0.0014
788 OFF LABEL USE 1218 0.0014
789 SWELLING 130 0.0014
790 WHITE BLOOD CELL COUNT DECREASED 150 0.0014
791 RASH PAPULAR 31 0.0014
792 PHOTOPHOBIA 26 0.0014
793 DRUG DISPENSING ERROR 21 0.0014
794 CARDIAC FAILURE CONGESTIVE 110 0.0014
795 DRUG INTOLERANCE 132 0.0014
796 PRODUCT AVAILABILITY ISSUE 31 0.0014
797 TINNITUS 62 0.0013
798 ABNORMAL BEHAVIOUR 53 0.0013
799 INTENTIONAL SELF-INJURY 27 0.0013
800 DISTURBANCE IN ATTENTION 72 0.0013
801 BLOOD CREATININE INCREASED 87 0.0013
802 GAIT DISTURBANCE 255 0.0013
803 VISUAL IMPAIRMENT 165 0.0013
804 MULTI-ORGAN FAILURE 23 0.0013
805 RASH PRURITIC 72 0.0013
806 LIMB DISCOMFORT 41 0.0013
807 PALLOR 36 0.0013
808 CORONARY ARTERY DISEASE 40 0.0013
809 COAGULOPATHY 22 0.0013
810 C-REACTIVE PROTEIN INCREASED 48 0.0013
811 PREMATURE DELIVERY 21 0.0013
812 ALOPECIA 259 0.0013
813 URINARY RETENTION 44 0.0013
814 HAEMATURIA 45 0.0013
815 TREMOR 218 0.0013
816 SENSORY DISTURBANCE 21 0.0013
817 COGNITIVE DISORDER 61 0.0013
818 MYALGIA 222 0.0013
819 NEEDLE ISSUE 38 0.0013
820 BLOOD PRESSURE FLUCTUATION 31 0.0013
821 FEELING HOT 79 0.0013
822 TACHYCARDIA 114 0.0013
823 SKIN FISSURES 25 0.0013
824 MUSCULOSKELETAL DISCOMFORT 22 0.0013
825 ARRHYTHMIA 60 0.0013
826 CRYING 46 0.0013
827 PSYCHOMOTOR HYPERACTIVITY 21 0.0013
828 BLISTER 71 0.0013
829 IMPAIRED WORK ABILITY 27 0.0013
830 SKIN DISCOLOURATION 58 0.0013
831 HYPOAESTHESIA ORAL 19 0.0013
832 THERAPY INTERRUPTED 90 0.0013
833 JOINT SWELLING 152 0.0013
834 ANHEDONIA 33 0.0013
835 NEUROTOXICITY 22 0.0013
836 DYSARTHRIA 47 0.0012
837 FACE OEDEMA 21 0.0012
838 PLATELET COUNT DECREASED 132 0.0012
839 DRY MOUTH 100 0.0012
840 TUBULOINTERSTITIAL NEPHRITIS 23 0.0012
841 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 221 0.0012
842 MENTAL STATUS CHANGES 34 0.0012
843 CARDIAC ARREST 101 0.0012
844 PULMONARY EMBOLISM 116 0.0012
845 INJECTION SITE MASS 45 0.0012
846 TOOTHACHE 22 0.0012
847 MUSCLE TWITCHING 28 0.0012
848 TOOTH DISORDER 27 0.0012
849 SWELLING FACE 79 0.0012
850 THERAPEUTIC RESPONSE UNEXPECTED 54 0.0012
851 HYPOAESTHESIA 180 0.0012
852 NEUTROPHIL COUNT DECREASED 49 0.0012
853 AGGRESSION 60 0.0012
854 HEART RATE IRREGULAR 27 0.0012
855 DIPLOPIA 31 0.0012
856 RASH 520 0.0012
857 INTENTIONAL PRODUCT USE ISSUE 104 0.0012
858 COLITIS ULCERATIVE 53 0.0012
859 ORAL HERPES 23 0.0012
860 NEUTROPENIA 160 0.0012
861 DISEASE PROGRESSION 139 0.0012
862 VISION BLURRED 161 0.0012
863 DEEP VEIN THROMBOSIS 76 0.0012
864 MYOCARDIAL INFARCTION 204 0.0012
865 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 20 0.0012
866 GLOSSODYNIA 26 0.0012
867 BREAST CANCER FEMALE 31 0.0012
868 METASTASES TO BONE 19 0.0012
869 HAEMORRHAGE 121 0.0012
870 BURNING SENSATION 81 0.0012
871 RHABDOMYOLYSIS 48 0.0011
872 SOMNOLENCE 231 0.0011
873 WOUND 32 0.0011
874 RASH MACULAR 40 0.0011
875 HYPERSENSITIVITY 212 0.0011
876 DRUG ADMINISTRATION ERROR 35 0.0011
877 ENCEPHALOPATHY 28 0.0011
878 MOUTH ULCERATION 24 0.0011
879 ARTHROPATHY 63 0.0011
880 AGITATION 83 0.0011
881 RASH ERYTHEMATOUS 54 0.0011
882 PLASMA CELL MYELOMA 44 0.0011
883 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 80 0.0011
884 RASH GENERALISED 29 0.0011
885 MEDICATION ERROR 62 0.0011
886 HALLUCINATION 84 0.0011
887 DEPRESSED LEVEL OF CONSCIOUSNESS 44 0.0011
888 URTICARIA 186 0.0011
889 EYE PAIN 62 0.0011
890 INFLUENZA LIKE ILLNESS 90 0.0011
891 ECZEMA 57 0.0011
892 BONE MARROW FAILURE 22 0.0011
893 LACTIC ACIDOSIS 35 0.0011
894 STEVENS-JOHNSON SYNDROME 24 0.0011
895 EYE SWELLING 40 0.0011
896 ACUTE RESPIRATORY DISTRESS SYNDROME 19 0.0011
897 DRUG DOSE OMISSION 176 0.0011
898 TOOTH LOSS 22 0.0011
899 PULMONARY HYPERTENSION 22 0.0011
900 BLOOD CHOLESTEROL INCREASED 49 0.0011
901 PALPITATIONS 123 0.0010
902 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 27 0.0010
903 WRONG TECHNIQUE IN DRUG USAGE PROCESS 38 0.0010
904 RESTLESS LEGS SYNDROME 19 0.0010
905 PRODUCT DOSE OMISSION ISSUE 307 0.0010
906 HALLUCINATION, VISUAL 22 0.0010
907 PARAESTHESIA 161 0.0010
908 ANAPHYLACTIC SHOCK 26 0.0010
909 PRURITUS 387 0.0010
910 SHOCK 23 0.0010
911 SKIN LESION 27 0.0010
912 FLUSHING 100 0.0010
913 ACUTE MYOCARDIAL INFARCTION 29 0.0010
914 EYE PRURITUS 33 0.0010
915 PRODUCT USE ISSUE 184 0.0010
916 ABNORMAL DREAMS 27 0.0010
917 HEPATIC FUNCTION ABNORMAL 36 0.0010
918 NERVOUS SYSTEM DISORDER 30 0.0010
919 PRODUCT USE IN UNAPPROVED INDICATION 232 0.0009
920 DRUG INEFFECTIVE 1216 0.0009
921 PERITONITIS 19 0.0009
922 RESPIRATORY ARREST 25 0.0009
923 ERYTHEMA 186 0.0009
924 MOVEMENT DISORDER 29 0.0009
925 LIVER INJURY 22 0.0009
926 DRY SKIN 119 0.0009
927 EYE IRRITATION 51 0.0009
928 EYE DISORDER 29 0.0009
929 MULTIPLE SCLEROSIS 42 0.0009
930 ACCIDENTAL OVERDOSE 32 0.0009
931 ACNE 66 0.0009
932 SKIN EXFOLIATION 73 0.0009
933 PREMATURE BABY 26 0.0009
934 LEUKOPENIA 43 0.0009
935 MUSCULOSKELETAL PAIN 44 0.0008
936 DEVICE DISLOCATION 36 0.0008
937 PRODUCT QUALITY ISSUE 112 0.0008
938 INTERSTITIAL LUNG DISEASE 39 0.0008
939 EXTRA DOSE ADMINISTERED 32 0.0008
940 CARDIO-RESPIRATORY ARREST 33 0.0008
941 HOT FLUSH 59 0.0008
942 OCULAR HYPERAEMIA 37 0.0008
943 ABASIA 19 0.0008
944 FOETAL EXPOSURE DURING PREGNANCY 61 0.0007
945 MUSCULOSKELETAL STIFFNESS 65 0.0007
946 EPILEPSY 22 0.0007
947 BONE DENSITY DECREASED 22 0.0007
948 VISUAL ACUITY REDUCED 23 0.0007
949 DYSKINESIA 28 0.0007
950 ANGINA PECTORIS 19 0.0007
951 PRODUCT SUBSTITUTION ISSUE 38 0.0007
952 ADVERSE EVENT 60 0.0007
953 INCORRECT ROUTE OF DRUG ADMINISTRATION 23 0.0006
954 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 129 0.0006
955 EMOTIONAL DISTRESS 75 0.0006
956 SUICIDE ATTEMPT 37 0.0006
957 INFUSION RELATED REACTION 40 0.0006
958 UNDERDOSE 43 0.0006
959 RENAL CANCER 28 0.0006
960 BREAST CANCER 54 0.0006
961 THERAPY NON-RESPONDER 26 0.0006
962 WITHDRAWAL SYNDROME 24 0.0006
963 DISEASE RECURRENCE 27 0.0006
964 RHEUMATOID ARTHRITIS 64 0.0006
965 DRUG EFFECT DECREASED 30 0.0006
966 ANGIOEDEMA 23 0.0005
967 DEVICE ISSUE 46 0.0005
968 INJURY 36 0.0005
969 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
970 PROSTATE CANCER 39 0.0005
971 INJECTION SITE HAEMORRHAGE 37 0.0005
972 INJECTION SITE PAIN 142 0.0005
973 BLADDER CANCER 27 0.0005
974 DEVICE LEAKAGE 19 0.0004
975 CONVULSION 25 0.0004
976 SKIN BURNING SENSATION 30 0.0004
977 TOXICITY TO VARIOUS AGENTS 68 0.0004
978 OVERDOSE 84 0.0004
979 PSORIASIS 50 0.0004
980 DRUG WITHDRAWAL SYNDROME 33 0.0004
981 INTENTIONAL OVERDOSE 24 0.0004
982 INJECTION SITE SWELLING 28 0.0004
983 NO ADVERSE EVENT 66 0.0004
984 INJECTION SITE BRUISING 28 0.0004
985 DEVICE MALFUNCTION 22 0.0003
986 COMPLETED SUICIDE 22 0.0003
987 INJECTION SITE ERYTHEMA 30 0.0002
988 DRUG DEPENDENCE 36 0.0002